ArticleAdvanced biomedical research2026
Ameliorating Effect of
Article in Advanced biomedical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Migration of autoreactive T cells into the brain and production of inflammatory cytokines play an undeniable role in the neuronal damage in multiple sclerosis (MS), and its animal model, experimental autoimmune encephalomyelitis (EAE). We investigated the immunomodulatory properties of Materials and Methods: EAE was induced in C57BL/6 mice using the MOG35-55 peptide. Mice were divided into control and lavender-treated groups, receiving phosphate-buffered saline or lavender extract (50 or 100 mg/kg), respectively. Clinical symptoms and body weight were recorded throughout the study, and leukocyte infiltration in brain tissues was evaluated postmortem. Lymphocyte proliferation and cytokine production were assessed using MTT and ELISA assays. Results: Lavender-treated mice showed a considerable amelioration in clinical symptoms and weight loss ( Conclusions: Our results cleared the immunomodulatory effects of lavender in the EAE model. Thus, this herb could be a new candidate for the reduction of damage induced by dysregulation of the immune system in MS and similar autoimmune situations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.